ClinicalTrials.gg
RecruitingNCT06502275Updated Sep 18, 2025

Nutrition and Exercise Program for Elderly Colorectal Cancer Patients

An interventional study of Mobile Health Management Frailty Care Program in Colorectal Cancer, sponsored by Chang Gung University of Science and Technology. Recruiting at 1 site in Taiwan. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-18.

Sponsored by Chang Gung University of Science and Technology · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Feb 2024, registered Jul 2024).
  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 165 studies in Colorectal Neoplasms with a site in Taiwan — 32 open to participants now, 52 under way, 11 of them phase 3. Colorectal Neoplasms · Taiwan.

Planned enrollment
86th of 137
140 · median 209
Started
2024
with 9 others
No phase
30 of 165
7 open now
Primary completion
2025-09
later than 4 of 51 live
Registered
141st of 165
by date

Among the 165 studies in Colorectal Neoplasms with a site in Taiwan, this one is the 86th largest by planned enrollment of the 137 interventional ones that give a count, is one of 10 that started in 2024, is one of 30 with no phase, reaches primary completion later than 4 of the 51 other live ones, and was the 141st registered.

Colorectal Neoplasms

6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.

Browse Colorectal Neoplasms studies →

Open to participants now

32 of the 165 studies in Colorectal Neoplasms with a site in Taiwan are open now. Recruiting first, the newest first:

27 more — sign in →

All 32 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.

This study: 60 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 165 studies in Colorectal Neoplasms with a site in Taiwan, or all of them as a file.
02

Study summary

The goal of this interventional study is to evaluate the effect of mobile health intervention on frailty, physical fitness, physical activity, and nutritional status of elderly patients with colorectal cancer. The main questions it aim to answer are: 1. Does the mobile health intervention reduce frailty in elderly colorectal cancer patients compared to standard care? 2. Does the mobile health intervention improve physical fitness, physical activity, and nutritional status in elderly colorectal cancer patients compared to standard care? Participants will receive the Mobile Health Management Frailty Care Program.

03

Conditions studied

  • Colorectal Cancer

Keywords

  • Older
  • Colorectal cancer
  • Frailty
  • mobile health
  • Physical activity
  • nutrition
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with colorectal cancer confirmed by a physician.
  • Aged 60 and above.
  • Have communication skills, able to read and write or converse in Mandarin and Taiwanese.
  • Clear consciousness and no mental or cognitive impairment.
  • Physical activities are accessible.
  • Those who have a smartphone and have experience using smartphones.

Exclusion criteria

Exclusion Criteria:

  • People who have difficulty walking or standing.
  • The wrist is not suitable for those wearing sports bracelets.
  • People in infectious or protective isolation.
  • Those who live alone or in institutions.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Nutrition combined with exercise group

    Provide mobile health interventions that combine nutrition and exercise

    Behavioral: Mobile Health Management Frailty Care Program

  • No intervention
    routine care group

    Provide routine care

Interventions

  • BehavioralMobile Health Management Frailty Care Program

    Through the "LINE" communication software, participants are provided with exercise and nutrition information three times a week, with a total of 36 messages. As well as 6 podcasts of health information and 6 sports videos in total. At weeks 2, 4, and 6, researchers scheduled 5- to 10-minute telephone consultations. Participants can receive guidance through telephone consultations and carry a Xiaomi sports band wearable device to monitor their exercise.

06

What researchers measure

Primary outcomes

  1. Frailty

    Assessing frailty status using the G8 geriatric screening tool. Scores range from 0 to 17, with 0 indicating severe impairment and 17 indicating no impairment. The lower the score, the more frail it is.

    Time frame: Pre-test, sixth week after intervention, 13th week after intervention

  2. Physical Activity

    Assess physical activity with the International Physical Activity Questionnaire-Short Form. The IPAQ-SF evaluates the number of days and time spent performing MVPA, walking, and sitting in bouts of at least 10 min over the previous 7 days. The summary score is expressed in PA metabolic equivalent of task (MET)-min per day or week.

    Time frame: Pre-test, sixth week after intervention, 13th week after intervention

  3. Nutritional Status

    Assess nutritional status with Mini Nutritional Assessment-Short Form. The total score is 0-14 points. A score of 12 or more indicates a low risk of malnutrition. A score of 8-11 indicates a potential risk of malnutrition. A score less than 7 indicates a high risk of malnutrition.

    Time frame: Pre-test, sixth week after intervention, 13th week after intervention

Secondary outcomes

  1. health-related quality of life

    Assessing quality of life using Taiwan Chinese version of European Organization for Research and Treatment of Cancer questionnaires. For all scales, item scores are summed and linearly transformed into a scale ranging from 0 to 100. Higher scores on the functioning scales indicate higher levels of functioning

    Time frame: Pre-test, sixth week after intervention, 13th week after intervention

  2. Depression

    Assessing depression level using the Geriatric Depression Scale Short Form. The higher the score, the higher the degree of depression. 0-4 indicates normal, 5-10 indicates slight tendency to depression, and 10 or more indicates symptoms of depression.

    Time frame: Pre-test, sixth week after intervention, 13th week after intervention

  3. body mass index

    Body mass index is calculated by dividing weight (kg) by height (meters) squared. The normal range is 18.5 ≦ BMI \< 24. Less than 18.5 represents underweight; 24 ≦ BMI \<27 represents overweight; 27 ≦ BM I\<30 represents mild obesity; 30 ≦ BMI \<35 represents moderate obesity; BMI ≧35 represents severe obesity.

    Time frame: Pre-test, sixth week after intervention, 13th week after intervention

  4. hand grip strength

    Hand grip strength (in kilograms) was measured using a digital hand dynamometer (EH101; Camry, Guangdong Province, China). The grip strength of the dominant hand was assessed three times, and the maximal value was considered for analysis. The definition of normal GS according to European Working Group on Sarcopenia in Older People (EWGSOP) was ≥ 30kg in the male and ≥ 20 kg in the female. Weak GS was defined as GS \< 30 kg in the male and GS \< 20 kg in the female.

    Time frame: Pre-test, sixth week after intervention, 13th week after intervention

  5. walking speed

    Walking speed was measured with a 4-meter walking evaluation with a static start. The 4-m gait speed was assessed to the nearest 0.01 s using a stopwatch. Participants were instructed to walk at their comfortable speed. Walking distance exceeded the required four meters to prevent participants from slowing down before reaching the 4-m line. The fastest time of two trials was used for analyses and gait speed was expressed in m/s. The 0.8 m/s cut-point was used to represent a slow walking speed.

    Time frame: Pre-test, sixth week after intervention, 13th week after intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Sep 2025, 19 months after the start.

Of 900 non-industry interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 61. This study's planned 19 months is below that.

Counting every sponsor, half of 958 studies reached it within 31 months; a quarter within 14 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2024
First posted
Jul 16, 2024
StartActual
Feb 1, 2024
Primary completionEst.
Sep 15, 2025
CompletionEst.
Sep 30, 2025
Last update
Sep 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06502275
Lead sponsor
Chang Gung University of Science and Technology
Responsible party
Ching-Ching Su (Assistant Professor, Chang Gung University of Science and Technology) — Principal investigator
First posted
Jul 16, 2024
Start date
Feb 1, 2024
Primary completion
Sep 15, 2025 (estimated)
Completion
Sep 30, 2025 (estimated)
Last update
Sep 18, 2025

Study contacts

Ching-Ching Su, PhD
Contact
ccsu@mail.cgust.edu.tw
886+912649476
Ching-Ching Su, PhD
principal investigator · Chang Gung University of Science and Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion